EUR 115.88 For Business Accounts Only

TILT Biotherapeutics Ltd - Company Review

TILT Biotherapeutics Ltd - Company Review

Summary

TILT Biotherapeutics Ltd (TILT Biotherapeutics) is a preclinical stage company which develops cancer immunotherapies using its patented technology. The company uses oncolytic viruses for enabling tumor T-cell therapy by tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR) and checkpoint inhibiting antibody therapy for solid tumor. Its pipeline portfolio includes TILT-123, the lead candidate, for the treatment of melanoma and other solid tumors. The company also offers TILT-234 for dendritic cell therapy and solid tumors; and TILT-321 for solid tumors. It uses T-cell therapy to extract T-cells from the cancer patient and treat in the lab with oncolytic viruses and transfer back into the same patient’s body. TILT Biotherapeutics is headquartered in Helsinki, Finland.

This comprehensive company report of TILT Biotherapeutics Ltd provides you with company's businesses and operations information.

The profile contains critical company information including,

- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.